Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans

被引:19
|
作者
Lo, Hsiu Jung [1 ,2 ]
Tseng, Kuo-Yun [1 ]
Kao, Yeong-Yi [3 ]
Tsao, Ming-Yang [1 ]
Lo, Han-Lun [3 ]
Yang, Yun-Liang [3 ,4 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan
[2] China Med Univ, Sch Dent, Taichung, Taiwan
[3] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[4] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan
关键词
Candida albicans; Drug resistance; Efflux pump; Virulence factor; Regulation; HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANCE; ANTIFUNGAL AGENTS; EFFLUX PUMP; CDR1; FLUCONAZOLE; CONTRIBUTE; GENE; CEREVISIAE; EXPRESSION;
D O I
10.1016/j.ijantimicag.2015.01.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The cph1/cph1 efg1/efg1 double mutant in Candida albicans is defective in filamentous growth and is avirulent in a mouse model. We previously reported that Efg1p but not Cph1p is involved in drug resistance by negatively regulating ERG3 in C. albicans. In the current study, we have found that overexpression of 0411 in Saccharomyces cerevisiae increases susceptibility to the antifungal drug fluconazole. Furthermore, in C. albicans, null mutation of 0411 increased the expression of MDR1 as well as decreased susceptibility to fluconazole and voriconazole but not to amphotericin B. These findings indicate that although Efg1p and Cph1p may have the same effects on virulence, they have opposite effects on drug resistance in C. albicans. (C) 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 50 条
  • [41] An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans
    Bruzual, Igor
    Kumamoto, Carol A.
    MOLECULAR GENETICS AND GENOMICS, 2011, 286 (5-6) : 347 - 357
  • [42] Chloroquine resistance in Plasmodium chabaudi:: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved?
    Hunt, P
    Cravo, PVL
    Donleavy, P
    Carlton, JMR
    Walliker, D
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2004, 133 (01) : 27 - 35
  • [43] Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans (vol 50, pg 1365, 2006)
    Hiller, D
    Sanglard, D
    Morschhäuser, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2591 - 2591
  • [44] MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells
    Ren Lirong
    Xiao Lan
    Hu Jianli
    Li Zhimin
    Wang Zehua
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2007, 27 (06) : 721 - 724
  • [45] MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells
    Lirong Ren
    Lan Xiao
    Jianli Hu
    Zhimin Li
    Zehua Wang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2007, 27 : 721 - 724
  • [46] Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate
    Norris, MD
    DeGraaf, D
    Haber, M
    Kavallaris, M
    Madafiglio, J
    Gilbert, J
    Kwan, E
    Stewart, BW
    Mechetner, EB
    Gudkov, AV
    Roninson, IB
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (05) : 613 - 619
  • [47] MDR1 P-glycoprotein expression and gastric cancer: Not only multi-drug resistance
    Rocco, A.
    Compare, D.
    Martin, G.
    D'Armiento, M.
    Budillon, G.
    Nardone, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 52 - 52
  • [48] Fluconazole-resistant clinical Candida albicans isolates show co-expression of MDR1 and CSH1
    Schulz, B.
    Weber, K.
    Ruhnke, M.
    MYCOSES, 2009, 52 (05) : 396 - 397
  • [49] Multidrug Resistance 1 (MDR1) Gene Polymorphisms in Childhood Drug-Resistant Epilepsy
    Alpman, Asude
    Ozkinay, Ferda
    Tekgul, Hasan
    Gokben, Sarenur
    Pehlivan, Sacide
    Schalling, Martin
    Ozkinay, Cihangir
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (12) : 1485 - 1490
  • [50] Egr-1 Enhances Drug Resistance of Breast Cancer Cells by MDR1 Dependence
    Gong, Pei-yao
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59